Zimmer Biomet Holdings (ZBH) Revenue — Quarter Ended Jun 30, 2025
Revenue for the quarter increased compared to the prior quarter and rose compared to the same quarter last year. The sequential and year-over-year growth reflects higher net sales reported in the period.
Key takeaway
Quarter ended Jun 30, 2025 · FY2025 Q2
Revenue for the quarter increased compared to the prior quarter and rose compared to the same quarter last year. The sequential and year-over-year growth reflects higher net sales reported in the period.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$2.1B
Revenue reported for this quarter.
Quarter-over-quarter
+8.8%
Change from the immediately preceding quarter.
Year-over-year
+7.0%
Change from the comparable year-ago quarter.
Trailing four quarters
$7.8B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Sep 30, 2024 | $1.8B | +4.0% |
| Dec 31, 2024 | $2B | +4.3% |
| Mar 31, 2025 | $1.9B | +1.1% |
| Jun 30, 2025 | $2.1B | +7.0% |
Revenue performance
The reported revenue direction is upward, with net sales higher than both the immediately preceding quarter and the same quarter one year earlier.
Quarterly comparison
Compared to the prior quarter, revenue increased, and compared to the same quarter a year ago, revenue also increased. The filing context does not provide specific drivers for these changes.
What to watch
Operating profit declined despite higher revenue, which may warrant attention to cost trends.